Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 þ breast cancer
Articolo
Data di Pubblicazione:
2019
Citazione:
Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 þ breast cancer / Hanker, A. B.; Estrada, M. V.; Bianchini, G.; Moore, P. D.; Zhao, J.; Cheng, F.; Koch, J. P.; Gianni, L.; Tyson, D. R.; Sanchez, V.; Rexer, B. N.; Sanders, M. E.; Zhao, Z.; Stricker, T. P.; Arteaga, C. L.. - In: CANCER RESEARCH. - ISSN 0008-5472. - 79:4(2019), pp. 873-873. [10.1158/0008-5472.CAN-18-4085]
Abstract:
In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Hanker, A. B.; Estrada, M. V.; Bianchini, G.; Moore, P. D.; Zhao, J.; Cheng, F.; Koch, J. P.; Gianni, L.; Tyson, D. R.; Sanchez, V.; Rexer, B. N.; Sanders, M. E.; Zhao, Z.; Stricker, T. P.; Arteaga, C. L.
Link alla scheda completa:
Pubblicato in: